NCT05839522

Australian Hepatitis and Risk Survey in Prisons

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,400 (estimated)
• Sponsor: Kirby Institute · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The Australian Hepatitis and risk survey in prisons (AusHep) is a national prison-based blood-borne virus (BBV) surveillance study. This biobehavioural survey involves point-of-care testing for hepatitis C (HCV) antibodies and RNA (if antibody positive), hepatitis B surface antigens, hepatitis B surface antibodies, and HIV surface antibodies, and an interview-style survey on prior testing and treatment history and engagement in risk behaviours. The study will recruit approximately 2400 prisoner participants from 25 representative prisons across Australia, annually.

Conditions

• Hepatitis C
• Hepatitis B
• HIV Infections

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Point-of-care hepatitis C antibody test	Qualitative point-of-care test for hepatitis C antibodies (saliva sample)
DIAGNOSTIC_TEST	Point-of-care hepatitis C RNA test	Hepatitis C Viral Load point-of-care test (fingerstick wholeblood sample)
DIAGNOSTIC_TEST	Point-of-care hepatitis B surface antibody test	Qualitative hepatitis B surface antibody point-of-care test (fingerstick wholeblood sample)
DIAGNOSTIC_TEST	Point-of-care hepatitis B surface antigen test	Qualitative hepatitis B surface antigen point-of-care test (fingerstick wholeblood sample)
DIAGNOSTIC_TEST	Point-of-care HIV antibody test	Qualitative HIV antibody point-of-care test (saliva sample)
BEHAVIORAL	Interview-style survey	Interview-style survey regarding demographics, risk behaviours, BBV testing and treatment history, and point-of-care testing acceptability

Timeline

• Start date: 2022-04-27
• Primary completion: 2023-05-01
• Completion: 2023-05-01
• First posted: 2023-05-03
• Last updated: 2023-05-03

Locations

24 sites across 1 country: Australia